Ginkgo Bioworks Holdings, Inc. (DNA) vs Sana Biotechnology, Inc. (SANA)
- Ginkgo Bioworks Holdings, Inc. DNA 10.27 −12.67%
- Sana Biotechnology, Inc. SANA 2.27 −8.47%
Ginkgo Bioworks Holdings, Inc. and Sana Biotechnology, Inc. are both Biotechnology companies. Ginkgo Bioworks Holdings, Inc. and Sana Biotechnology, Inc. are of similar size ($791.9M and $740.9M). Sana Biotechnology, Inc. has the higher net margin (0.00% vs −219.6%) and the higher return on invested capital (0.00% vs −161.9%). Across the 13 metrics below, Sana Biotechnology, Inc. leads on 7 and Ginkgo Bioworks Holdings, Inc. on 6.
Valuation
Profitability
| Metric | DNA | SANA | Biotechnology median |
|---|---|---|---|
| Gross margin | 68.04% | 0.00% | 65.16% |
| Operating margin | (231.13%) | 0.00% | 0.00% |
| Net margin | (219.60%) | 0.00% | 0.00% |
| Free cash flow margin | (131.57%) | 0.00% | 0.00% |
| Return on equity | (56.29%) | (152.87%) | (56.36%) |
| Return on assets | (26.19%) | (53.41%) | (48.04%) |
| Return on invested capital | (161.94%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack